CYP2A6*4/*4 (whole gene deletion) was found in only one female patient in this subgroup (Table 5), whereas among 387 lung cancer patients, CYP2A6*4/*4 was detected in seven patients (1.8%) with lung adenocarcinoma. The gene discussed is CYP2A6; the disease is lung cancer.